4O Liquid biopsy-guided selection for anti-EGFR re-treatment in RAS/BRAF wild-type (wt) chemorefractory metastatic colorectal cancer patients (mCRC pts): Results from the phase II randomized PARERE trial
Title:
4O Liquid biopsy-guided selection for anti-EGFR re-treatment in RAS/BRAF wild-type (wt) chemorefractory metastatic colorectal cancer patients (mCRC pts): Results from the phase II randomized PARERE trial
Author:
Ciracì, P. Germani, M.M. Pietrantonio, F. Lonardi, S. Busico, A. Chiaramonte, A. Ricagno, G. Esposto, R. Formica, V. Scartozzi, M. Burgio, V. Di Donato, S. Moretto, R. Capone, I. Bertuzzi, F. Marmorino, F. Taravella, A. Boni, L. Rossini, D. Cremolini, C.